0.008
price up icon0.00%   0.00
 
loading
Geovax Labs Inc stock is traded at $0.008, with a volume of 4,971. It is up +0.00% in the last 24 hours and down -55.31% over the past month. GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for HIV, chronic Hepatitis B infections, and solid tumor cancers. The company is developing GEO-CM04S1, a vaccine candidate that is in Phase 2 clinical trial for the treatment of preventive COVID-19; Gedeptin, a novel patented product/technology for the treatment of solid tumors, and Phase 1/2 clinical trial for the treatment of advanced head and neck squamous cell carcinoma; and GEO-CM02, a pan-coronavirus vaccine. In addition, it is also developing GEO-ZM02, a vaccine candidate, which is in preclinical trial for the treatment of GEO-ZM02, a vaccine candidate, which is in preclinical trial for the treatment of Zika; GEO-MM02 treatment for malaria; GEO-EM01 for the treatment of fever viruses, such as Ebola, Sudan, and Marburg; GEO-LM01 for the treatment of Lassa fever. GeoVax Labs, Inc. has collaboration and partnership agreements with the National Institute of Allergy and Infectious Diseases of the National Institutes of Health; U.S. Department of Defense; Emory University; and the Burnet Institute. GeoVax Labs, Inc. was incorporated in 1988 and is headquartered in Smyrna, Georgia.
See More
Previous Close:
$0.008
Open:
$0.0091
24h Volume:
4,971
Relative Volume:
0.31
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+0.00%
1M Performance:
-55.31%
6M Performance:
-88.56%
1Y Performance:
-97.02%
1-Day Range:
Value
$0.008
$0.00925
1-Week Range:
Value
$0.0079
$0.0094
52-Week Range:
Value
$0.0077
$0.27

Geovax Labs Inc Stock (GOVXW) Company Profile

Name
Name
Geovax Labs Inc
Name
Phone
678 384 7220
Name
Address
1900 Lake Park Drive, Suite 380, Smyrna
Name
Employee
14
Name
Twitter
Name
Next Earnings Date
Name
Latest SEC Filings
Name
GOVXW's Discussions on Twitter

Compare GOVXW with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
GOVXW
Geovax Labs Inc
0.008 0 0 0 0 0.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
394.53 99.62B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
465.89 61.52B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
560.00 58.91B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ARGX
Argen X Se Adr
756.38 46.69B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
324.34 34.54B 3.81B -644.79M -669.77M -6.24

Geovax Labs Inc Stock (GOVXW) Latest News

pulisher
Sep 14, 2025

Can GeoVax Labs Inc. Equity Warrant hit a new high this monthEarnings Recap Report & Low Risk High Win Rate Stock Picks - newser.com

Sep 14, 2025
pulisher
Sep 14, 2025

What machine learning models say about GeoVax Labs Inc.2025 Technical Overview & Free Fast Entry Momentum Trade Alerts - newser.com

Sep 14, 2025
pulisher
Sep 14, 2025

Earnings visualization tools for GeoVax Labs Inc. Equity WarrantCPI Data & Weekly Setup with High ROI Potential - newser.com

Sep 14, 2025
pulisher
Sep 14, 2025

Signal strength of GeoVax Labs Inc. stock in tech scannersDollar Strength & Consistent Return Investment Signals - newser.com

Sep 14, 2025
pulisher
Sep 14, 2025

Published on: 2025-09-14 19:05:01 - newser.com

Sep 14, 2025
pulisher
Sep 14, 2025

Will breakout in GeoVax Labs Inc. Equity Warrant lead to full recoveryPortfolio Update Summary & Risk Managed Trade Strategies - newser.com

Sep 14, 2025
pulisher
Sep 14, 2025

Can GeoVax Labs Inc. Equity Warrant recover in the next quarterTrade Entry Report & Fast Exit and Entry Strategy Plans - newser.com

Sep 14, 2025
pulisher
Sep 14, 2025

Risk vs reward if holding onto GeoVax Labs Inc.Volume Spike & Weekly High Potential Alerts - newser.com

Sep 14, 2025
pulisher
Sep 14, 2025

Institutional scanner results for GeoVax Labs Inc. Equity WarrantWeekly Market Summary & Momentum Based Trading Ideas - newser.com

Sep 14, 2025
pulisher
Sep 14, 2025

Is this a good reentry point in GeoVax Labs Inc.Weekly Trade Recap & Weekly Hot Stock Watchlists - newser.com

Sep 14, 2025
pulisher
Sep 14, 2025

How to build a dashboard for GeoVax Labs Inc. stock2025 Support & Resistance & Daily Profit Focused Stock Screening - newser.com

Sep 14, 2025
pulisher
Sep 14, 2025

How high can GeoVax Labs Inc. stock go2025 Market Outlook & Stepwise Entry and Exit Trade Signals - newser.com

Sep 14, 2025
pulisher
Sep 14, 2025

Will GeoVax Labs Inc. Equity Warrant bounce back from current supportWeekly Profit Analysis & Reliable Breakout Stock Forecasts - newser.com

Sep 14, 2025
pulisher
Sep 14, 2025

How moving averages guide GeoVax Labs Inc. tradingMarket Activity Recap & Entry Point Confirmation Signals - newser.com

Sep 14, 2025
pulisher
Sep 14, 2025

GeoVax Labs Inc. stock trend outlook and recovery pathPortfolio Update Report & Verified Chart Pattern Signals - newser.com

Sep 14, 2025
pulisher
Sep 14, 2025

How sentiment analysis helps forecast GeoVax Labs Inc. Equity WarrantTrade Analysis Summary & Real-Time Buy Zone Alerts - newser.com

Sep 14, 2025
pulisher
Sep 14, 2025

News impact scoring models applied to GeoVax Labs Inc.Forecast Cut & AI Forecast Swing Trade Picks - newser.com

Sep 14, 2025
pulisher
Sep 14, 2025

How to forecast GeoVax Labs Inc. Equity Warrant trends using time seriesMarket Activity Recap & Stepwise Entry and Exit Trade Signals - newser.com

Sep 14, 2025
pulisher
Sep 13, 2025

Understanding GeoVax Labs Inc. Equity Warrant’s price movementPortfolio Risk Summary & Safe Capital Allocation Plans - newser.com

Sep 13, 2025
pulisher
Sep 13, 2025

Will GeoVax Labs Inc. see short term momentumTrade Analysis Summary & Safe Capital Growth Tips - newser.com

Sep 13, 2025
pulisher
Sep 13, 2025

Has GeoVax Labs Inc. formed a bullish divergenceDip Buying & Free Weekly Watchlist of Top Performers - newser.com

Sep 13, 2025
pulisher
Sep 12, 2025

How high can GeoVax Labs Inc. Equity Warrant stock go2025 Market Trends & Community Supported Trade Ideas - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

GeoVax Labs Inc. Equity Warrant stock outlook for YEARJuly 2025 Closing Moves & AI Forecasted Stock Moves - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

Will earnings trigger a reversal in GeoVax Labs Inc.Quarterly Profit Review & Community Consensus Trade Signals - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

Can you recover from losses in GeoVax Labs Inc.2025 Dividend Review & Weekly Setup with ROI Potential - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

Tools to monitor GeoVax Labs Inc. recovery probabilityPortfolio Value Report & Safe Entry Momentum Tips - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

GeoVax Labs Inc. Equity Warrant stock trendline breakdownInflation Watch & Breakout Confirmation Alerts - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

GeoVax Labs Inc. recovery potential after sell off2025 Market Outlook & Momentum Based Trading Signals - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

Exit strategy if you’re trapped in GeoVax Labs Inc.Entry Point & Long-Term Safe Return Strategies - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

Technical signs of recovery in GeoVax Labs Inc. Equity WarrantJuly 2025 Pullbacks & Proven Capital Preservation Tips - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

GeoVax Showcases Promising GEO-CM04S1 Clinical Data at the European Society of Clinical Microbiology and Infectious Disease (ESCMID) Conference - Yahoo Finance

Sep 12, 2025
pulisher
Sep 12, 2025

What momentum shifts mean for GeoVax Labs Inc. Equity WarrantPortfolio Risk Summary & Accurate Trade Setup Notifications - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

Multi asset correlation models including GeoVax Labs Inc.Portfolio Update Summary & Risk Managed Trade Strategies - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

How to recover losses in GeoVax Labs Inc. stock2025 Technical Overview & Low Drawdown Investment Strategies - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

Will GeoVax Labs Inc. stock go up soonTrade Entry Report & High Accuracy Trade Alerts - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

Using Python tools to backtest GeoVax Labs Inc. strategies2025 Institutional Moves & Daily Chart Pattern Signals - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

Monkeypox Vaccine Market May See a Big Move | GeoVax Labs, Novavax, Pfizer - newstrail.com

Sep 12, 2025
pulisher
Sep 12, 2025

Should you hold or exit GeoVax Labs Inc. now2025 Breakouts & Breakdowns & Daily Profit Maximizing Trade Tips - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

analyzing geovax labs inc. with multi timeframe chartsTrade Exit Report & Consistent Profit Alerts - Newser

Sep 12, 2025
pulisher
Sep 11, 2025

What earnings revisions data tells us about GeoVax Labs Inc.July 2025 Snapshot & Reliable Intraday Trade Alerts - Newser

Sep 11, 2025
pulisher
Sep 11, 2025

How to use a screener to detect GeoVax Labs Inc. Equity Warrant breakoutsJuly 2025 Trade Ideas & Smart Swing Trading Techniques - Newser

Sep 11, 2025
pulisher
Sep 11, 2025

Can swing trading help recover from GeoVax Labs Inc. lossesGap Up & AI Forecast Swing Trade Picks - Newser

Sep 11, 2025
pulisher
Sep 11, 2025

Comparing GeoVax Labs Inc. Equity Warrant in custom built stock radarsQuarterly Trade Report & Technical Pattern Recognition Alerts - Newser

Sep 11, 2025
pulisher
Sep 11, 2025

Should you hold or exit GeoVax Labs Inc. Equity Warrant nowQuarterly Market Summary & Daily Chart Pattern Signal Reports - Newser

Sep 11, 2025
pulisher
Sep 11, 2025

Momentum divergence signals in GeoVax Labs Inc. Equity Warrant chart2025 Year in Review & Real-Time Stock Entry Alerts - Newser

Sep 11, 2025

Geovax Labs Inc Stock (GOVXW) Financials Data

There is no financial data for Geovax Labs Inc (GOVXW). Check out other stocks for more information.

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$36.36
price down icon 0.93%
$83.10
price down icon 3.56%
$27.82
price down icon 2.76%
$96.74
price down icon 7.26%
$145.93
price up icon 0.10%
biotechnology ONC
$324.34
price down icon 3.38%
Cap:     |  Volume (24h):